Full-Time

Quality Compliance Specialist 3

Posted on 11/22/2024

ProKidney

ProKidney

51-200 employees

Develops cell therapy for chronic kidney disease

Biotechnology
Healthcare

Mid

Winston-Salem, NC, USA

Category
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Strong understanding of cGMP regulations, including 21 CFR Parts 210, 211, 11, and Eudralex.
  • Familiarity with the full scope of manufacturing, packaging, regulatory affairs, compliance, clinical, and quality assurance requirements for biological and medical product manufacturing.
  • Exceptional attention to detail and organizational skills.
  • Ability to interpret and apply technical documents, regulations, and industry standards.
  • Strong report-writing, business correspondence, and procedure development skills.
  • Ability to analyze complex data, define problems, and draw sound conclusions.
  • Proficient in Microsoft Office Suite (Word, Excel, PowerPoint).
  • Excellent decision-making skills and sound judgment in high-pressure situations.
  • Bachelor’s degree in a scientific discipline or equivalent experience.
  • Minimum of 4–6 years of relevant experience in a regulated medical, pharmaceutical, or biotechnology environment with a strong focus on cGMP compliance.
  • Demonstrated experience in auditing (vendor, internal, and external audits) and Management of Change (MOC).
  • Experience in leading and executing quality assurance or compliance initiatives, such as audit programs, quality agreements, and corrective actions.
  • Solid understanding of regulatory requirements (e.g., FDA, EU, ICH, ISO) and industry guidelines.
  • Experience supporting or participating in regulatory inspections and understanding the inspection process.
  • Prior experience working with cross-functional teams (e.g., manufacturing, quality control, clinical, regulatory) is highly preferred.
  • Auditor certification (e.g., Certified Quality Auditor (CQA)) is a plus.
Responsibilities
  • Maintain and manage the Approved Vendor List (AVL).
  • Oversee and update the Vendor Audit Schedule.
  • Execute vendor audits/assessments, ensure timely follow-up on any observations or concerns.
  • Author and manage Quality Agreements with approved vendors.
  • Lead investigations stemming from the Vendor Complaint and Vendor Change Notification program, ensuring that all potential impacts on ProKidney’s Quality Management System are thoroughly documented and addressed.
  • Act as the point of contact for vendor communications related to quality and compliance matters.
  • Manage and maintain the Internal Audit Schedule.
  • Plan and execute internal audits, ensuring they align with procedural requirements.
  • Review, approve, and track internal audit documentation, ensuring proper follow-up and execution of audit responses.
  • Communicate effectively with GMP stakeholders regarding audit findings and actions.
  • Provide support during GMP audits of ProKidney.
  • Assist in developing and executing responses to audit findings, including necessary documentation.
  • Support GMP stakeholders in the identification, establishment, execution, and completion of MOC documentation, including impact assessments and action plans.
  • Act as the administrator for MOC documentation.
  • Provide technical expertise to support quality decisions and resolve quality issues.
  • Collaborate with site leaders and stakeholders to drive continuous improvement in quality compliance activities.
  • Support cross-functional teams in project completion, quality issue resolution, and implementation of quality systems improvements.
  • Influence peers to ensure compliance with internal SOPs and global regulations.
  • Identify and implement continuous improvement opportunities across functional areas such as manufacturing, facilities, and Quality Control.
  • Maintain GMP departmental databases, ensuring accurate data tracking and follow-up.
  • Identify and communicate compliance risks, providing action plans for mitigation.
  • Escalate critical quality issues to senior management as needed.
  • Stay current on industry trends, standards, and best practices as they relate to cGxP.
  • Perform other duties as assigned by the Manager, Quality Compliance.

ProKidney focuses on treating Chronic Kidney Disease (CKD) through a novel cell therapy called rilparencel. This therapy aims to preserve kidney function in patients with advanced CKD, potentially delaying or eliminating the need for dialysis, which is often the only option for these patients. ProKidney is currently in the late stages of clinical trials, with early data indicating that rilparencel could effectively maintain kidney function. Unlike many competitors, ProKidney specifically targets the CKD market, which affects over 35 million adults in the U.S., and aims to fill a critical gap in treatment options. The company's goal is to provide a groundbreaking alternative to dialysis, significantly improving the quality of life for CKD patients.

Company Stage

IPO

Total Funding

$559.3M

Headquarters

Winston-Salem, North Carolina

Founded

N/A

Growth & Insights
Headcount

6 month growth

22%

1 year growth

44%

2 year growth

101%
Simplify Jobs

Simplify's Take

What believers are saying

  • Successful $140 million public and direct offering boosts financial stability and supports ongoing R&D efforts.
  • The potential approval and commercialization of rilparencel could revolutionize CKD treatment and significantly improve patient quality of life.
  • Expansion plans, including a new facility in Greensboro, promise job creation and economic growth.

What critics are saying

  • The biotech sector's inherent volatility, as evidenced by ProKidney's significant stock price fluctuations, could impact financial stability.
  • Dependence on the successful approval and commercialization of rilparencel means any regulatory setbacks could severely affect the company's prospects.

What makes ProKidney unique

  • ProKidney is pioneering a novel cell therapy, rilparencel, specifically targeting CKD, unlike many competitors who focus on broader therapeutic areas.
  • Their focus on delaying or eliminating the need for dialysis offers a unique value proposition in the CKD treatment landscape.
  • ProKidney's late-stage clinical trials and promising early data position it as a frontrunner in CKD cell therapy innovation.

Help us improve and share your feedback! Did you find this helpful?